Blog
RSS FeedPosted by Michael Wonder on 08 Dec 2017
Post-market review of the use of biologics in the treatment of severe chronic plaque psoriasis - stakeholder forum outcome
8 December 2017 - A stakeholder forum was held for the post-market review of the use of biologics in the ...
Posted by Michael Wonder on 12 Nov 2017
Evaluation of patient and public involvement initiatives in health technology assessment: a survey of international agencies
10 November 2017 - Although there is increased awareness of patient and public involvement among health technology assessment organisations, evaluations of ...
Posted by Michael Wonder on 26 Oct 2017
Exploration and preferential ranking of patient benefits of medical devices: a new and generic instrument for health economic assessments
25 October 2017 - For medical devices, benefits other than direct clinical effects may have a large impact on the patients’ ...
Posted by Michael Wonder on 26 Oct 2017
Taking patient heterogeneity and preferences into account in health technology assessments
25 October 2017 - The INTEGRATE-HTA project provided methodology to evaluate complex technologies. ...
Posted by Michael Wonder on 06 Oct 2017
EMA takes yet another step in public engagement with its first public hearing
6 October 2017 - Summary report now published. ...
Posted by Michael Wonder on 26 Sep 2017
Drugs watchdog NICE attacks pharmaceutical industry in pricing dispute
25 September 2017 - Industry expert’s evidence is not independent, NICE argues. ...
Posted by Michael Wonder on 06 Sep 2017
Medical devices sponsor information day - 2017
6 September 2017 - TheTGA invites medical device sponsors and their staff to attend the Medical Devices Sponsor Information Day in ...
Posted by Michael Wonder on 01 Sep 2017
Provisional approval pathway for prescription medicines
1 September 2017 - The TGA would like to thank respondents who provided submissions in response to the March 2017 ...
Posted by Michael Wonder on 23 Aug 2017
Health Minister hears consumer case for health reform
23 August 2017 - Healthcare consumers have today put the case to Health Minister, Greg Hunt, for his National Health ...
Posted by Michael Wonder on 01 Aug 2017
Nomenclature of biological medicines
28 July 2017 - The TGA is seeking comments from interested parties on proposed options on whether there is a need ...
Posted by Michael Wonder on 29 Jul 2017
Concept paper on development and lifecycle of personalised medicines and companion diagnostic
28 July 2017 - Public consultation to end on 31 October 2017. ...
Posted by Michael Wonder on 25 Jul 2017
ICER seeks public comment on proposed value assessment framework for treatments that represent a potential major advance for serious ultra-rare conditions
25 July 2017 - ICER’s fundamental approach to value assessment remains constant with proposed changes for special circumstances. ...
Posted by Michael Wonder on 25 Jul 2017
PBAC to conduct stakeholder forum on the post-market review of the use of biologics in the treatment of severe chronic plaque psoriasis
25 July 2017 - A stakeholder forum will be held for the post-market review of the use of biologics in the ...
Posted by Michael Wonder on 13 Jul 2017
Proposed revision to the procedure for the CADTH Common Drug Review and the CADTH Therapeutic Review Framework
13 July 2017 - CADTH is inviting stakeholder comments and feedback on proposed revisions to the Procedure for the CADTH Common ...
Posted by Michael Wonder on 19 May 2017
Post-market review of ezetimibe – notice of public consultation
19 May 2017 - The public consultation on the revised draft ezetimibe post-market review report to the PBAC will open ...